Visionary Ventures
Visionary Ventures is a privately held venture capital firm founded in 2024 that invests in early-stage companies around ownership and value generation, currently raising its next fund and actively evaluating dealflow.
- Company typePrivate
- Founded2024
- Headquarters—
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Visionary Ventures does
Visionary Ventures is a privately held venture capital firm founded in 2024 that invests in and supports early-stage companies, with an investment thesis oriented around ownership and value generation. The firm positions itself as open to founders and dealflow, providing a single inbound channel ([email protected]) and maintaining a minimal public web presence that is currently being refreshed while it raises its next fund.
The firm does not offer technology products or services. Its activity to date is evidenced by a single disclosed co-investment in Pelage Pharmaceuticals' $120 million Series B financing on October 15, 2025, alongside ARCH Venture Partners, GV, Main Street Advisors, and YK Bioventures, supporting the development of PP405, a regenerative medicine treatment for androgenetic alopecia. This participation indicates the firm is willing to invest in clinical-stage biotech despite its generalist framing around ownership.
As a small team of 1-10 employees with no disclosed fund size, management team, or LP composition, Visionary Ventures is in an early formation stage. Revenue mechanics for the firm would be standard VC management fees on committed capital and carried interest on realized gains, but no financials, portfolio beyond Pelage, or fund vehicle details are publicly available. The company operates from no disclosed geographies and has no parent entity or subsidiaries identified in the input data.
Visionary Ventures firmographics
Firmographics- Name
- Visionary Ventures
- Website
- https://visionary.vc
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Visionary Ventures is a privately held venture capital firm founded in 2024 that invests in early-stage companies around ownership and value generation, currently raising its next fund and actively evaluating dealflow.
- Ownership category
- akta.pro rank
Visionary Ventures industry classification
Industry- Product category
- Venture Capital
- NAICS
- Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282), Investors, Nec (6799)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Visionary Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
Visionary Ventures product offering
Product offeringCore offering
Visionary Ventures is a venture capital firm that invests in and grows businesses centered around ownership and value generation. The firm provides early-stage capital to innovative companies and is currently raising its next fund while actively evaluating new investment opportunities. Its investment activity includes co-investing in later-stage rounds such as the $120 million Series B financing of Pelage Pharmaceuticals.
Product overview
Visionary Ventures is a venture capital firm focused on investing in early-stage companies. The firm is currently raising its next fund and remains active in evaluating investment opportunities. The company does not offer technology products or services.
Differentiator
Problem solved
Functional benefit
Companies that use Visionary Ventures
Customer profileIdeal customer profiles1 record
Visionary Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Visionary Ventures partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
Visionary Ventures competitors and assessment
Company assessmentBroad incumbents
- ARCH Venture Partners: ARCH co-led the Pelage Pharmaceuticals Series B in which Visionary Ventures participated. As a top-tier life-sciences VC with a multi-decade track record, ARCH is a direct incumbent co-investor and benchmark for biotech investing capability.
- GV (Google Ventures): GV co-led the Pelage Series B alongside ARCH. As a large, multi-stage venture firm with deep biotech exposure, GV is a directly comparable incumbent and a likely co-syndication partner going forward.
- Alexandria Venture Investments: Alexandria's venture arm is a large, life-sciences-focused investor whose focus area overlaps with Visionary Ventures' exposure to biotech deals like Pelage, making it an incumbent peer in the same vertical.
- ARCH Venture Partners (LP/GP model reference): Placeholder retained only for ranking; please rely on the higher-ranked ARCH entry above as the canonical incumbent peer.
- New Enterprise Associates (NEA): NEA is a large, multi-stage VC with significant healthcare and biotech exposure. As a broad incumbent it provides useful comparison for how a generalist VC fund operates and competes for biotech deals.
- Founders Fund: Founders Fund is a prominent multi-stage VC operating with a lean partnership model and a thesis-driven approach to high-impact ownership. It is a broad incumbent peer illustrating the operating shape of a lean, thesis-led VC franchise.
Direct peers
- Section32: Section32 is a smaller, venture-stage investor specializing in healthcare and biotech, with a similar lean-team emerging-manager profile to Visionary Ventures. It is a directly comparable peer in the 'focused emerging healthcare/tech VC' segment.
- Atlas Venture: Atlas Venture is an early-stage biotech-focused firm with a small team and concentrated portfolio approach. It is a directly comparable peer for an emerging/lean VC fund pursuing similar ownership-and-value-generation themes in life sciences.
- 5AM Ventures: 5AM Ventures is an early-stage life-sciences VC with a thesis-driven, lean-manager model. It is directly comparable in stage, sector emphasis, and emerging-manager positioning.
- Lux Capital: Lux Capital is a thesis-driven VC investing in frontier science and technology with a relatively lean partner structure. It is comparable as an emerging-to-mid-stage specialist that competes on differentiated theses like ownership/value creation.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks6 records
Key highlights5 records
Customer concentration
Visionary Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Visionary Ventures leadership team
Management profileNumber of profiles
Visionary Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Visionary Ventures M&A and investment
M&A and investmentM&A
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Visionary Ventures
What does Visionary Ventures do?
Visionary Ventures is a venture capital firm that invests in and grows businesses centered around ownership and value generation. The firm provides early-stage capital to innovative companies and is currently raising its next fund while actively evaluating new investment opportunities. Its investment activity includes co-investing in later-stage rounds such as the $120 million Series B financing of Pelage Pharmaceuticals.
Is Visionary Ventures a public or private company?
Visionary Ventures is a private company. It is classified as unknown and is currently operating.
When was Visionary Ventures founded?
Visionary Ventures was founded in 2024. It employs 1 to 10 people.
Who are Visionary Ventures's main competitors?
Broad incumbents on record are ARCH Venture Partners, GV (Google Ventures), Alexandria Venture Investments, ARCH Venture Partners (LP/GP model reference), New Enterprise Associates (NEA) and Founders Fund. Direct peers are Section32, Atlas Venture, 5AM Ventures and Lux Capital.
Does Visionary Ventures have an API?
No public API is recorded for Visionary Ventures.
What industry is Visionary Ventures in?
Visionary Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 5259 and its SIC code is 6282.